1. Home
  2. LIDR vs STTK Comparison

LIDR vs STTK Comparison

Compare LIDR & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$2.21

Market Cap

118.0M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.10

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
STTK
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
119.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LIDR
STTK
Price
$2.21
$3.10
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$6.00
$4.00
AVG Volume (30 Days)
1.5M
328.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$182,000.00
$1,000,000.00
Revenue This Year
$2.76
N/A
Revenue Next Year
$2,830.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.69
52 Week High
$6.44
$3.38

Technical Indicators

Market Signals
Indicator
LIDR
STTK
Relative Strength Index (RSI) 38.15 68.57
Support Level $2.30 $1.93
Resistance Level $2.79 $3.30
Average True Range (ATR) 0.17 0.24
MACD -0.02 0.06
Stochastic Oscillator 0.85 77.24

Price Performance

Historical Comparison
LIDR
STTK

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: